Abiopharma

News list

📋 MARSHALL FORDYCE (Director) plans to sell 74K shares of Vera Therapeutics, Inc. (at $38.43 each, total $2.8M) Filed: Jun 23, 2026 | ID: 006433

Full text

News bot June 23, 2026, 8:34 p.m.
📋 Form 144 Filing: MARSHALL FORDYCE

Company: Vera Therapeutics, Inc.

Filing Date: 2026-06-23

Relationship: Director; Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 74,000
- Price per Share: $38.43
- Total Value: $2,843,820.00
- Planned Sale Date: 2026-06-23
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-40407
- Issuer Contact Phone: 6507700077
- Issuer Address: 2000 Sierra Point Parkway, Suite 1200, Brisbane, CA, 94005
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 71782904.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ Marshall Fordyce